首页> 外文期刊>International Journal of Obesity >Implication of gut microbiota in the association between infant antibiotic exposure and childhood obesity and adiposity accumulation
【24h】

Implication of gut microbiota in the association between infant antibiotic exposure and childhood obesity and adiposity accumulation

机译:肠道微生物肿瘤在婴儿抗生素暴露与儿童肥胖和肥胖积累之间的含义

获取原文
           

摘要

In animal studies early life antibiotic exposure causes metabolic abnormalities including obesity through microbiota disruption, but evidence from human studies is scarce. We examined involvement of gut microbiota in the associations between infant antibiotic exposure and childhood adiposity. Infant antibiotic exposure in the first year of life was ascertained using parental reports during interviewer-administered questionnaires. Primary outcomes were childhood obesity [body mass index (BMI) z-score->-95th percentile] and adiposity [abdominal circumference (AC) and skinfold (triceps-+-subscapular (SST)) measurements] determined from ages 15-60 months. At age 24 months, when the gut microbiota are more stable, stool samples (n-=-392) were collected for the gut microbiota profiling using co-abundancy networks. Associations of antibiotic exposure with obesity and adiposity (n-=-1016) were assessed using multiple logistic and linear mixed effects regressions. Key bacteria associated with antibiotics exposure were identified by partial redundancy analysis and multivariate association with linear models. Antibiotic exposure was reported in 38% of study infants. In a fully adjusted model, a higher odds of obesity from 15-60 months of age was observed for any antibiotic exposure [OR(95% CI)-=-1.45(1.001, 2.14)] and exposure to 3 courses of antibiotics [2.78(1.12, 6.87)]. For continuous adiposity indicators, any antibiotic exposure was associated with higher BMI z-score in boys [β-=-0.15(0.01, 0.28)] but not girls [β-=--0.04(-0.19, 0.11)] (P interaction-=-0.026). Similarly, exposure to 3 courses of antibiotics was associated with higher AC in boys [1.15(0.05, 2.26)-cm] but not girls [0.57(-1.32, 2.45)-cm] (P interaction not significant). Repeated exposure to antibiotics was associated with a significant reduction (FDR-corrected P values-<-0.05) in a microbial co-abundant group (CAG) represented by Eubacterium hallii, whose proportion was negatively correlated with childhood adiposity. Meanwhile, a CAG represented by Tyzzerella 4 was positively correlated with the repeated use of antibiotics and childhood adiposity. Infant antibiotic exposure was associated with disruption of the gut microbiota and the higher risks of childhood obesity and increased adiposity.
机译:在动物研究中,早期生命抗生素暴露会导致代谢异常,包括通过微生物群中断的肥胖,但来自人类研究的证据是稀缺的。我们研究了肠道微生物群在婴儿抗生素暴露和儿童肥胖之间的关联中的参与。在采访者管理的问卷期间,使用父母报告确定生命的第一年婴儿抗生素暴露。初级结果是儿童肥胖[体重指数(BMI)z评分 - > - 95百分位]和肥胖[腹部圆周(AC)和肤色(Triceps - + - 船只(SST))测量]从15-60岁以下确定。 24个月,当肠道微生物达更稳定时,使用共同丰富的网络收集肠样品(N - = - 392)的肠道微生物植物分析。使用多重逻辑和线性混合效应回归评估抗生素暴露与肥胖和肥胖度(N - = - 1016)的关联。通过部分冗余分析和与线性模型多变量关联鉴定与抗生素暴露相关的关键细菌。在38%的研究婴儿中报道了抗生素暴露。在完全调整的模型中,对于任何抗生素暴露[或(95%CI) - = - 1.45(1.001,2.14)]和接触3种抗生素疗法[2.78 (1.12,6.87)]。对于连续肥胖指标,任何抗生素暴露都与男孩的较高BMI Z评分相关[β - = - 0.15(0.01,0.28)]但不是女孩[β - = - 0.04(-0.19,0.11)](P互动 - = - 0.026)。同样,暴露于3种抗生素的疗法与男孩中的高度疗法有关[1.15(0.05,2.26)-cm]但不是女孩[0.57(-1.32,2.45)-cm](P互动不显着)。重复暴露于抗生素与由哈利杆菌表示的微生物共居群(CAG)中的显着减少(FDR校正的P值 - < - 0.05)相关,其比例与儿童肥胖呈负相关。同时,由Tyzzerella 4表示的CAG与抗生素和儿童肥胖的重复使用呈正相关。婴儿抗生素暴露与肠道微生物的破坏有关,儿童肥胖的风险较高,肥胖增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号